COVID-19 could worsen cerebral amyloid angiopathy

J Neuropathol Exp Neurol. 2023 Aug 21;82(9):814-817. doi: 10.1093/jnen/nlad049.

Authors

Julie Dewisme¹, Thibaud Lebouvier², Quentin Vannod-Michel³; Lille COVID Research Network (LICORNE); Vincent Prevot¹, Claude-Alain Maurage¹

Affiliations

¹ Development and Plasticity of the Neuroendocrine Brain, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, UMR-S 1172, Lille, France.
² Alzheimer and Tauopathy, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, UMR-S 1172, Lille, France.
³ Neuroradiology Department, Lille University, Medical Centre, Lille, France.

PMID: 37428895
DOI: 10.1093/jnen/nlad049

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / complications
Cerebral Amyloid Angiopathy* / complications
Cerebral Hemorrhage
Humans